Plasmacytoma
📧 Sign up to get email alerts when something new happens for Plasmacytoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma [Phase 1]
Phase 1 trial evaluating adding KRT-232 (AMG 232) to standard chemotherapy in relapsed multiple myeloma, with plasmacytoma also listed; the …
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating a conditioning regimen with panobinostat, gemcitabine hydrochloride, busulfan, and melphalan before stem cell tra…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome [EARLY_Phase 1]
Clinical trial update on an early-phase 1 study of ixazomib citrate, lenalidomide, and dexamethasone for POEMS syndrome (plasmacytoma) that …
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: T-cell Receptor α/β Depleted Donor Lymphocyte Infusion [Phase 1]
Phase 1 trial of T-cell receptor α/β-depleted donor lymphocyte infusion was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer [Phase 1]
Phase 1 clinical trial evaluating the combination of sodium selenite with radiation therapy in patients with metastatic cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-23Clinical Trial Update: Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma [Phase 3]
Phase 3 trial investigating an immunomodulatory therapy for high-risk solitary bone plasmacytoma is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma [Phase 2]
Phase 2 trial evaluating daratumumab in combination with DCEP for relapsed multiple myeloma with plasmacytoma.
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma [Phase 1]
This ClinicalTrials.gov record reports a completed Phase 1 trial evaluating a dendritic cell-based idiotype vaccination in Stage I multiple …